Delivery Order SPE2DB22D1106-SPE2DB24FFLW5

Award Date 9/9/24
Potential Completion Date 9/10/24
Potential Value $5.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $62,352.78, is for the delivery of the medication Bupropion HCL XL 150 mg tablets in 500-count bottles. The contract has a firm fixed price pricing type and an ultimate completion date of March 14, 2024. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a...
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of 500 tablets of Bupropion HCL XL 150 mg. The contract has a total potential value of $2,209.29 and a completion date of February 8, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued at up to $999,999,999.00 and running through...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $27,268.05, is for the delivery of bupropion HCL XL 150 mg tablets in 500-count packages. The contract is a firm fixed-price delivery order with a period of performance ending on March 4, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The order, valued at $1,814.29, is for the supply of Bupropion HCL XL 300 mg tablets. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,327,324 units of Bupropion HCL XL 150 mg tablets. The contract has a firm fixed price of $58,443.58 and a period of performance through April 19, 2024. Amerisourcebergen, a major pharmaceutical distributor, will provide these prescription medications to support military treatment programs and facilities globally...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 500 tablets of Bupropion HCL XL 300 mg. The contract has an ultimate completion date of April 28, 2025 and a ceiling value of $9,771.22. The contract is not set-aside and was awarded on April 25, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,133,134 units of Bupropion HCL XL 150 mg tablets. The contract has a ceiling value of $42,999.30 and a performance period through April 2, 2024. This delivery order contract is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, valued at up to $999,999,999.00...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The delivery order, valued at $12,723.06, is for the supply of 4,564,083,598 units of Bupropion HCL XL 150 mg tablets to DLA Troop Support Medical facilities supporting the Department of Defense. The delivery order falls under a larger indefinite delivery contract (IDC) awarded...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,598.98 firm fixed price delivery order is for the supply of 4,563,970,057 units of the prescription medication Bupropion HCL XL 150 mg tablets. The contract has an ultimate completion date of March 15, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued at up to...
Amerisourcebergen Drug Corp, through its Corporate Office division, has been awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide 4563692636 - BUPROPION HCL XL 150 MG TABLET 500S. The order has a potential value of $19,253.37 and a completion date of February 20, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB24FFLW5
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of Bupropion HCl XL 150 mg tablets. The firm fixed-price contract, valued at $5,484.55, has an ultimate completion date of September 10, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this delivery order as well as multiple Indefinite Delivery Contracts (IDCs) by the DLA and other federal agencies, such as the Department of Justice Federal Bureau of Investigation, to provide a comprehensive range of pharmaceutical and medical supplies to support various government healthcare programs and facilities. The contract does not have a set-aside designation.

Generated 12/9/24, 2:00 PM